10-Q Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 Q2 2019

Filing Information

Form Type	10-Q
Accession Number	`0001144204-19-037248`
Period End Date	20190630
Filing Date	20190801
Fiscal Year	2019
Fiscal Period	Q2
XBRL Instance	iova-20190630x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 32 Cash Flow Statement 53 Stockholders Equity 42 Comprehensive Income 12

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$76.91M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$246.02M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$82.15M	USD	Point-in-time
Short-term investments	`AvailableForSaleSecuritiesCurrent`	$327.24M	USD	Point-in-time
Short-term investments	`AvailableForSaleSecuritiesCurrent`	$386.37M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.64M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.79M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$475.16M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$410.94M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$11.72M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$10.40M	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common Stock, Par or Stated Value Per Share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.47M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.68M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	123.42M	shares	Point-in-time
Restricted cash	`RestrictedCash`	$5.45M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	123.82M	shares	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$3.35M	USD	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$2.98M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	123.42M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	123.82M	shares	Point-in-time
Total Assets	`Assets`	$435.92M	USD	Point-in-time
Total Assets	`Assets`	$480.82M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$12.78M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.74M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$13.57M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$11.66M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$4.90M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$7.48M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$33.84M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$14.40M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$4.61M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$5.80M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$230.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$53.00K	USD	Point-in-time
Total Non-Current Liabilities	`LiabilitiesNoncurrent`	$230.00K	USD	Point-in-time
Total Non-Current Liabilities	`LiabilitiesNoncurrent`	$4.67M	USD	Point-in-time
Total Liabilities	`Liabilities`	$14.63M	USD	Point-in-time
Total Liabilities	`Liabilities`	$38.50M	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.000041666 par value; 300,000,000 and 150,000,000 shares authorized, 123,820,508 and 123,415,576 shares issued and outstanding as of June 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$5.00K	USD	Point-in-time
Common stock, $0.000041666 par value; 300,000,000 and 150,000,000 shares authorized, 123,820,508 and 123,415,576 shares issued and outstanding as of June 30, 2019 and December 31, 2018, respectively	`CommonStockValue`	$5.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$-42.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$372.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$854.60M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$838.98M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-372.76M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-457.56M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$270.57M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$434.93M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$466.19M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$292.56M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$397.42M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$145.48M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$435.92M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$480.82M	USD	Point-in-time

Income Statement 32 line items

Line Item	Tag	Value	Unit	Period
Research and development expenses	`ResearchAndDevelopmentExpense`	$24.55M	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpense`	$44.46M	USD	2 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpense`	$70.20M	USD	2 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpense`	$39.30M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$13.79M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$6.83M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$19.95M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$10.87M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$50.16M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$90.15M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$58.26M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$31.38M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-50.16M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-58.26M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-31.38M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-90.15M	USD	2 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$2.61M	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$5.65M	USD	2 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$718.00K	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$1.08M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-57.17M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-47.55M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-30.66M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-84.50M	USD	2 Qtrs
Net Loss Per Common Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.65	USD	2 Qtrs
Net Loss Per Common Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.38	USD	1 Quarter
Net Loss Per Common Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.68	USD	2 Qtrs
Net Loss Per Common Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.34	USD	1 Quarter
Weighted Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	90,236.00	shares	1 Quarter
Weighted Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	123,567.00	shares	1 Quarter
Weighted Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	123,491.00	shares	2 Qtrs
Weighted Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	87,310.00	shares	2 Qtrs

Cash Flow Statement 53 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-57.17M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-47.55M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-30.66M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-84.50M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$560.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$453.00K	USD	2 Qtrs
Noncash lease expense	`NonCashLeaseExpense`	$3.03M	USD	2 Qtrs
Loss on disposal of assets	`GainLossOnDispositionOfAssets`	$-9.00K	USD	2 Qtrs
Gain on settlement of dispute	`GainLossRelatedToLitigationSettlement`	$336.00K	USD	2 Qtrs
Accretion of discounts on investments	`AmortizationOfDebtDiscountPremium`	$-2.43M	USD	2 Qtrs
Accretion of discounts on investments	`AmortizationOfDebtDiscountPremium`	$-1.00K	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$9.33M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$12.27M	USD	2 Qtrs
Prepaid expenses, other assets, and long-term assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.60M	USD	2 Qtrs
Prepaid expenses, other assets, and long-term assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$515.00K	USD	2 Qtrs
Operating lease liabilities (Right-of-use assets)	`IncreaseDecreaseInOperatingLeaseRightOfUseAsset`	$-2.65M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$9.95M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$3.69M	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$1.73M	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$326.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-62.88M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-41.77M	USD	2 Qtrs
Maturities of short-term investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$263.10M	USD	2 Qtrs
Purchase of short-term investments	`PaymentsToAcquireAvailableForSaleSecurities`	$201.13M	USD	2 Qtrs
Purchase of short-term investments	`PaymentsToAcquireAvailableForSaleSecurities`	$30.08M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.26M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$440.00K	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$59.72M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-30.52M	USD	2 Qtrs
Tax payments related to shares withheld for vested restricted stock awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$95.00K	USD	2 Qtrs
Tax payments related to shares withheld for vested restricted stock awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$122.00K	USD	2 Qtrs
Proceeds from the issuance of common stock upon exercise of warrants	`ProceedsFromWarrantExercises`	$4.14M	USD	2 Qtrs
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$3.47M	USD	2 Qtrs
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$6.83M	USD	2 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$162.09M	USD	2 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$236.70M	USD	Point-in-time
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$172.94M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.38M	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$210.00K	USD	2 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$100.64M	USD	2 Qtrs
Cash, Cash Equivalents, and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$145.37M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$82.36M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$246.02M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$82.15M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$145.37M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$82.36M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$246.02M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$82.15M	USD	Point-in-time
Unrealized gain (loss) on short-term investments	`UnrealizedGainLossOnShorttermInvestments`	$-3.00K	USD	2 Qtrs
Unrealized gain (loss) on short-term investments	`UnrealizedGainLossOnShorttermInvestments`	$414.00K	USD	2 Qtrs
Acquisitions of property and equipment included in accounts payable	`LeaseholdImprovementsPaidByLandlord`	$92.00K	USD	2 Qtrs
Acquisitions of property and equipment included in accounts payable	`LeaseholdImprovementsPaidByLandlord`	$278.00K	USD	2 Qtrs
Conversion of convertible preferred stock to common stock	`ConversionOfStockAmountConverted1`	$1.00K	USD	2 Qtrs

Stockholders Equity 42 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$270.57M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$434.93M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$466.19M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$292.56M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$397.42M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$145.48M	USD	Point-in-time
Adoption of ASU 2018-07	`CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption`	$300.00K	USD	Point-in-time
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$5.22M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.43M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$12.27M	USD	2 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$9.33M	USD	2 Qtrs
Vesting of restricted shares issued for services	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	$-1.00K	USD	1 Quarter
Tax payments related to shares withheld for vested restricted stock awards	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-23.00K	USD	1 Quarter
Tax payments related to shares withheld for vested restricted stock awards	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-94.00K	USD	2 Qtrs
Tax payments related to shares withheld for vested restricted stock awards	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-122.00K	USD	2 Qtrs
Tax payments related to shares withheld for vested restricted stock awards	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-62.00K	USD	1 Quarter
Common stock issued upon exercise of warrants	`CommonStockIssuedUponExerciseOfWarrantsAmount`	$4.14M	USD	2 Qtrs
Common stock issued upon exercise of warrants	`CommonStockIssuedUponExerciseOfWarrantsAmount`	$2.31M	USD	1 Quarter
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.40M	USD	1 Quarter
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.47M	USD	2 Qtrs
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.20M	USD	1 Quarter
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.83M	USD	2 Qtrs
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$414.00K	USD	2 Qtrs
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-3.00K	USD	2 Qtrs
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$234.00K	USD	1 Quarter
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-3.00K	USD	1 Quarter
Common stock sold in public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$162.09M	USD	2 Qtrs
Common stock sold in public offering, net of offering costs (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	25.30M	shares	Point-in-time
Common stock sold in public offering, net of offering costs (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	17,500.00	shares	1 Quarter
Common stock sold in public offering, net of offering costs (in shares)	`StockIssuedDuringPeriodSharesNewIssues`	50,000.00	shares	Point-in-time
Conversion of convertible preferred stock into common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$1.00K	USD	1 Quarter
Cancellation of common shares from settlement of dispute	`StockCancelledDuringPeriodSharesOfCommonStock`	$-336.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-57.17M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-47.55M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-30.66M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-84.50M	USD	2 Qtrs
Ending Balance	`StockholdersEquity`	$270.57M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$434.93M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$466.19M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$292.56M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$397.42M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$145.48M	USD	Point-in-time

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-57.17M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-47.55M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-30.66M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-84.50M	USD	2 Qtrs
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$414.00K	USD	2 Qtrs
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-3.00K	USD	2 Qtrs
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$234.00K	USD	1 Quarter
Unrealized gain / (loss) on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-3.00K	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-57.18M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-84.09M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-47.32M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-30.66M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.